← American Pharmacists Association (APhA)
FDANonrulemakingFDA-2025-N-6895

Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments--Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List

RIN
—
Last modified
Jul 2, 2026
Comment window
closed 6d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Jul 10, 2026 and Jul 10, 2026. 31 other organizations filed here. The comment window closed 6d ago.

What American Pharmacists Association (APhA) filed (1)

Jul 10, 2026· Comment from American Pharmacists Association (APhA)· FDA-2025-N-6895-1694

Dear Deputy Commissioner Graham and Members of the Pharmacy Compounding Advisory Committee, The American Pharmacists Association (APhA) appreciates the opportunity to provide FDA and the Pharmacy Compounding Advisory Committee (PCAC) with comments on the "Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List." Full comments are attached.

Download attachment ↓View on regulations.gov →

Abstract

Open

View on regulations.gov →

Co-filers (31)

See everyone who commented →